Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication - Concepedia

Concepedia

Publication | Open Access

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication

DOI Full Paper Access

55

Citations

38

References

1994

Year

Wim H.J. Kruit, K. Punt, S.H. Goey, P H de Mulder, D C van Hoogenhuyze, Sonja C. Henzen‐Logmans, G. Stoter

Abstract

This intensive treatment schedule of IL-2 and alpha-IFN is prohibited by severe and life-threatening cardiac toxicity.

References

	Year	Citations

Page 1